MRI in the Management of Prostate Cancer: What Urologists Need to Know
Dr. Michael S. Cookson, MD, MMHC, discusses the advantages of using MRI for the enhanced detection of prostate cancer, as opposed to traditional biopsy.
Read MoreSelect Page
Posted by Michael S. Cookson, MD, MMHC | Jan 2018
Dr. Michael S. Cookson, MD, MMHC, discusses the advantages of using MRI for the enhanced detection of prostate cancer, as opposed to traditional biopsy.
Read MorePosted by David C. Beyer, MD | Jan 2018
David C. Beyer, MD, reviews recent data regarding external beam radiation, brachytherapy, and androgen deprivation therapy (ADT) as it relates to radiation oncology and prostate cancer treatment.
Read MorePosted by Phillip J. Koo, MD | Jan 2018
Dr. Phillip J. Koo, MD, discusses the use of radiopharmaceuticals in prostate cancer treatment, as well as the area of theranostics. He goes into detail on the process of choosing these radiopharmaceuticals and trying to determine the best ones to use in various situations in regards to prostate cancer.
Read MorePosted by Ryan P. Terlecki, MD, FACS | Jan 2018
Dr. Ryan P. Terlecki, MD, FACS, discusses bladder neck contractures and the causes behind them, the possible sources of the symptoms, the outcomes of what has been done in the past, and what could potentially work in the future.
Read MorePosted by David C. Beyer, MD | Jan 2018
David C. Beyer, MD, argues that there is enough research from randomized trials and clinical studies for the urological community to consider high intensity focused ultrasound (HIFU) as a standard of care for treating prostate cancer patients.
Read More